Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
作者信息
Morris R E, Huang X, Gregory C R, Billingham M E, Rowan R, Shorthouse R, Berry G J
机构信息
Department of Cardiothoracic Surgery, Stanford University School of Medicine, California 94305-5247, USA.
